Medication info
Candesartan Plus Tablet

Candesartan Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Shinpoong Pharmaceutical Co., Ltd.
Appearance
Biconvex light pink rectangular tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200904235 · Notified 2009.06.17 · Insurance code 648504990

Summary

Main use
Treatment of essential hypertension inadequately controlled with individual ingredients
Who takes it
Adults
Adult dose
The recommended dose is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this medicine. When clinically appropriate, direct switching from monotherapy to this medicine may be considered. The antihypertensive effect is usually achieved within 4 weeks of starting treatment. 2) Older adults: No dose adjustment of this medicine is necessary for older adults. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance below 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Ingredients

Manufacturer
Shinpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with individual ingredients

  • Essential hypertension
View approved original text

Essential hypertension is a condition where blood pressure remains persistently high, which may be difficult to manage with a single medication. This medicine works with multiple components to effectively lower blood pressure and reduce the risk of complications arising from hypertension. It helps to manage blood pressure stably through combination therapy. Therefore, it is used for the treatment of essential hypertension.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this medicine. When clinically appropriate, direct switching from monotherapy to this medicine may be considered. The antihypertensive effect is usually achieved within 4 weeks of starting treatment. 2) Older adults: No dose adjustment of this medicine is necessary for older adults. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance below 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Precautions

This drug can cause serious harm or even death to the fetus and newborn, especially during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug's ingredients or sulfonamide derivatives, pregnant women or those planning a pregnancy, nursing mothers, those with severe renal or hepatic dysfunction, etc., should not take this medication. Patients with excessively low blood pressure or issues regarding fluid and electrolyte balance, certain heart conditions, gout, the elderly, etc. should use this medication cautiously, and it is important to consult a physician before taking it. During treatment, blood pressure, renal function, electrolyte levels, etc. should be monitored regularly to closely observe for adverse reactions or side effects. The hydrochlorothiazide component may lower potassium levels in the body, so potassium levels should be carefully monitored when combined with potassium supplements or potassium-sparing diuretics. This drug may interact with other antihypertensive agents, diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), etc., so it is essential to inform healthcare providers of any other medications being taken. The hydrochlorothiazide component can react sensitively to sunlight, potentially increasing the risk of skin cancer, so it is important to avoid sun exposure and pay attention to sun protection during treatment. This drug can pass into breast milk, so nursing mothers should avoid taking it or discontinue breastfeeding, and the safety of this medication for children and adolescents under 18 years has not been established. In case of overdose, symptoms may include low blood pressure, dizziness, electrolyte imbalances, etc., so if symptoms occur, consult a medical professional immediately for appropriate treatment. Finally, this drug should be kept out of reach of children and stored in its original container to prevent quality degradation or misuse.

Side effects

  • headache
  • back pain
  • dizziness
  • respiratory infections
  • symptoms similar to influenza
  • sinusitis
  • bronchitis
  • urinary tract infections
  • nausea
  • contusion
Show 72 more
  • tachycardia
  • fatigue
  • abdominal pain
  • pharyngitis
  • atrioventricular block
  • vomiting
  • hyperlipidemia
  • nasopharyngitis
  • cough
  • elevated blood sugar
  • increased serum uric acid
  • elevated ALT (SGPT)
  • decreased hemoglobin
  • increased serum AST (SGOT)
  • increased creatinine
  • increased urea
  • elevated potassium
  • decreased sodium
  • leukopenia
  • neutropenia
  • agranulocytosis
  • vertigo
  • intestinal vascular edema
  • diarrhea
  • renal failure
  • angioedema
  • rash
  • urticaria
  • pruritus
  • arthralgia
  • myalgia
  • hyperkalemia
  • hyponatremia
  • elevated liver enzymes
  • abnormal liver function
  • hepatitis
  • deep vein thrombosis
  • sensory disturbances
  • transient blurred vision
  • choroidal exudate
  • acute myopia
  • acute angle-closure glaucoma
  • dyspnea
  • acute respiratory distress syndrome
  • anorexia
  • loss of appetite
  • gastrointestinal irritation
  • constipation
  • pancreatitis
  • interstitial nephritis
  • rash
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • skin erythematosus lupus-like reaction
  • activation of erythematosus lupus
  • muscle spasms
  • hyperglycemia
  • hyperuricemia
  • electrolyte imbalance
  • orthostatic hypotension
  • necrotizing vasculitis
  • weakness
  • fever
  • anaphylactic reaction
  • jaundice
  • sleep disorders
  • depression
  • anxiety
  • edema
  • myalgia
  • hypercalcemia
  • ear pain

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to protect it from air or moisture, and it is recommended to keep it at a cool temperature below 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness over time.

Appearance and packaging

Appearance

Biconvex light pink rectangular tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.